Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.

Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB.

AJR Am J Roentgenol. 2013 Dec;201(6):1260-7. doi: 10.2214/AJR.13.10673.

PMID:
24261365
2.

Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.

Rosenkrantz AB, Haghighi M, Horn J, Naik M, Hardie AD, Somberg MB, Melamed J, Xiao GQ, Huang WC, Taouli B.

AJR Am J Roentgenol. 2013 Dec;201(6):1254-9. doi: 10.2214/AJR.12.10348.

PMID:
24261364
3.

Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.

Wang H, Cheng L, Zhang X, Wang D, Guo A, Gao Y, Ye H.

Radiology. 2010 Oct;257(1):135-43. doi: 10.1148/radiol.10092396. Epub 2010 Aug 16.

PMID:
20713607
4.

Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.

Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A, Iyer VK, Das P.

Acta Radiol. 2012 Apr 1;53(3):349-58. doi: 10.1258/ar.2011.110415.

PMID:
22496427
5.

Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.

Akita H, Jinzaki M, Kikuchi E, Sugiura H, Akita A, Mikami S, Kuribayashi S.

AJR Am J Roentgenol. 2011 Nov;197(5):1130-6. doi: 10.2214/AJR.10.6299.

PMID:
22021505
6.

Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.

Choi YA, Kim CK, Park SY, Cho SW, Park BK.

AJR Am J Roentgenol. 2014 Jul;203(1):W78-84. doi: 10.2214/AJR.13.11551.

PMID:
24951231
7.

Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.

Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J.

AJR Am J Roentgenol. 2010 Nov;195(5):W344-51. doi: 10.2214/AJR.10.4688.

PMID:
20966299
8.

Centrally infiltrating renal masses on CT: differentiating intrarenal transitional cell carcinoma from centrally located renal cell carcinoma.

Raza SA, Sohaib SA, Sahdev A, Bharwani N, Heenan S, Verma H, Patel U.

AJR Am J Roentgenol. 2012 Apr;198(4):846-53. doi: 10.2214/AJR.11.7376.

PMID:
22451550
9.

Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.

Rosenkrantz AB, Wehrli NE, Melamed J, Taneja SS, Shaikh MB.

Eur J Radiol. 2014 Aug;83(8):1311-6. doi: 10.1016/j.ejrad.2014.05.016. Epub 2014 May 17.

PMID:
24882784
10.

Utility of apparent diffusion coefficients in the evaluation of solid renal tumors at 3T.

Sasamori H, Saiki M, Suyama J, Ohgiya Y, Hirose M, Gokan T.

Magn Reson Med Sci. 2014;13(2):89-95. Epub 2014 Apr 28.

11.

Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging.

Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A.

Radiology. 2012 Apr;263(1):160-8. doi: 10.1148/radiol.12111205. Epub 2012 Feb 17.

PMID:
22344404
12.

Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.

Rheinheimer S, Stieltjes B, Schneider F, Simon D, Pahernik S, Kauczor HU, Hallscheidt P.

Eur J Radiol. 2012 Mar;81(3):e310-6. doi: 10.1016/j.ejrad.2011.10.016. Epub 2011 Nov 21.

PMID:
22104090
13.

Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.

Zhang YD, Wu CJ, Wang Q, Zhang J, Wang XN, Liu XS, Shi HB.

AJR Am J Roentgenol. 2015 Aug;205(2):W193-201. doi: 10.2214/AJR.14.13802.

PMID:
26204307
14.

Predictive Value of Chemical-Shift MRI in Distinguishing Clear Cell Renal Cell Carcinoma From Non-Clear Cell Renal Cell Carcinoma and Minimal-Fat Angiomyolipoma.

Jhaveri KS, Elmi A, Hosseini-Nik H, Hedgire S, Evans A, Jewett M, Harisinghani M.

AJR Am J Roentgenol. 2015 Jul;205(1):W79-86. doi: 10.2214/AJR.14.13245.

PMID:
26102422
15.

Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.

Wang HJ, Pui MH, Guo Y, Li SR, Guan J, Zhang XL, Cai HS.

AJR Am J Roentgenol. 2015 Feb;204(2):330-4. doi: 10.2214/AJR.14.13147.

PMID:
25615755
16.

Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.

Cornelis F, Lasserre AS, Tourdias T, Deminière C, Ferrière JM, Le Bras Y, Grenier N.

AJR Am J Roentgenol. 2013 Apr;200(4):830-8. doi: 10.2214/AJR.12.9122.

PMID:
23521457
17.

Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.

Erbay G, Koc Z, Karadeli E, Kuzgunbay B, Goren MR, Bal N.

Acta Radiol. 2012 Apr 1;53(3):359-65. doi: 10.1258/ar.2011.110601. Epub 2012 Feb 14.

PMID:
22334870
18.

Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.

Maruyama M, Yoshizako T, Uchida K, Araki H, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H.

Acta Radiol. 2015 Feb;56(2):250-6. doi: 10.1177/0284185114523268. Epub 2014 Feb 11.

PMID:
24518687
19.

Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.

Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A.

Eur J Radiol. 2013 Nov;82(11):1870-6. doi: 10.1016/j.ejrad.2013.07.008. Epub 2013 Aug 6.

PMID:
23932396
20.

Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Notohamiprodjo M, Staehler M, Steiner N, Schwab F, Sourbron SP, Michaely HJ, Helck AD, Reiser MF, Nikolaou K.

Acad Radiol. 2013 Jun;20(6):685-93. doi: 10.1016/j.acra.2013.01.015.

PMID:
23664397
Items per page

Supplemental Content

Write to the Help Desk